A creator covers how peptides work, how they show up in hair care, and whether they are safe to use. No study or source is cited for the hair claims.
Recap by typeshit. Post by @gunjantalks on Instagram.
EMY covers findings suggesting GLP-1 drugs such as Wegovy could lower the risk of certain cancers. Details on which cancers are in the full story.
Shah points to research published September 2 in which older mice given semaglutide lived longer, with effects he says went beyond blood sugar control.
The review weighs weight and metabolic benefits in people with IBD against early lab hints of anti-inflammatory effects, and looks at what observational studies show so far.
The obesity doctor takes on why some people see weaker results on GLP-1 medications. Short clip with few details given.
The agency is flagging risks from unapproved GLP-1 products sold for weight loss, with retatrutide named among them. Only a headline is available so far.
A short piece on the effectiveness of Novo Nordisk's oral version of Wegovy. Only the headline is available, so tap through for the findings.
Loading…